Balanced mix of new substance developments and life cycle management opportunities
In this context, Bayer HealthCare Pharmaceuticals focuses on its core competencies and its many years of experience. We thus hold a leading position in many therapeutic fields: for instance in the treatment of hemophilia and multiple sclerosis, in contrast media and oral contraception. We are also striving for such a leading position in oncology. With new approaches in cancer therapy, cardiovascular diseases and gynaecological therapies Bayer HealthCare Pharmaceuticals seeks to become an innovation leader in these fields.
In addition, Bayer HealthCare Pharmaceuticals is further developing currently marketed products in order to improve their application and/or extend the range of indications.
The following table sets forth our development projects including the respective indication, therapeutic area and development status. Click on Phase I to III to learn more about our pipeline.
Research and Development
More information about the topic Research and Development: